tiprankstipranks
Trending News
More News >
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
India Market
Advertisement

Dr. Lal PathLabs Limited (LALPATHLAB) Price & Analysis

Compare
0 Followers

LALPATHLAB Stock Chart & Stats


LALPATHLAB FAQ

What was Dr. Lal PathLabs Limited’s price range in the past 12 months?
Dr. Lal PathLabs Limited lowest stock price was ₹2295.10 and its highest was ₹3645.00 in the past 12 months.
    What is Dr. Lal PathLabs Limited’s market cap?
    Dr. Lal PathLabs Limited’s market cap is ₹277.46B.
      When is Dr. Lal PathLabs Limited’s upcoming earnings report date?
      Dr. Lal PathLabs Limited’s upcoming earnings report date is Nov 06, 2025 which is in 66 days.
        How were Dr. Lal PathLabs Limited’s earnings last quarter?
        Dr. Lal PathLabs Limited released its earnings results on Jul 31, 2025. The company reported ₹15.887 earnings per share for the quarter, beating the consensus estimate of ₹14.278 by ₹1.609.
          Is Dr. Lal PathLabs Limited overvalued?
          According to Wall Street analysts Dr. Lal PathLabs Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Dr. Lal PathLabs Limited pay dividends?
            Dr. Lal PathLabs Limited pays a Quarterly dividend of ₹6 which represents an annual dividend yield of 0.72%. See more information on Dr. Lal PathLabs Limited dividends here
              What is Dr. Lal PathLabs Limited’s EPS estimate?
              Dr. Lal PathLabs Limited’s EPS estimate is 18.19.
                How many shares outstanding does Dr. Lal PathLabs Limited have?
                Dr. Lal PathLabs Limited has 83,775,510 shares outstanding.
                  What happened to Dr. Lal PathLabs Limited’s price movement after its last earnings report?
                  Dr. Lal PathLabs Limited reported an EPS of ₹15.887 in its last earnings report, beating expectations of ₹14.278. Following the earnings report the stock price went up 1.648%.
                    Which hedge fund is a major shareholder of Dr. Lal PathLabs Limited?
                    Currently, no hedge funds are holding shares in IN:LALPATHLAB

                    Company Description

                    Dr. Lal PathLabs Limited

                    Dr. Lal PathLabs Limited (LALPATHLAB) is a leading diagnostic and healthcare service provider in India, renowned for offering a wide range of diagnostic and related healthcare services. Established with a focus on quality and reliability, the company operates a network of laboratories, patient service centers, and pick-up points across the country. Its core services include routine and specialized testing services in areas such as biochemistry, hematology, clinical pathology, microbiology, and molecular diagnostics, catering to the needs of patients, physicians, and hospitals.

                    Dr. Lal PathLabs Limited (LALPATHLAB) Earnings & Revenues

                    LALPATHLAB Stock 12 Month Forecast

                    Average Price Target

                    ₹3,454.33
                    ▲(4.30% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2343":"₹2,343","2725":"₹2,725","3107":"₹3,107","3489":"₹3,489","3871":"₹3,871"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3870,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹3.87K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3454.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹3.45K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3000,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹3.00K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2343,2725,3107,3489,3871],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Jan<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3169.08,3222.996923076923,3276.913846153846,3330.830769230769,3384.7476923076924,3438.6646153846154,3492.5815384615385,3546.4984615384615,3600.4153846153845,3654.3323076923075,3708.249230769231,3762.166153846154,3816.083076923077,{"y":3870,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3169.08,3191.0223076923075,3212.964615384615,3234.906923076923,3256.849230769231,3278.7915384615385,3300.733846153846,3322.6761538461537,3344.6184615384614,3366.560769230769,3388.503076923077,3410.4453846153847,3432.3876923076923,{"y":3454.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3169.08,3156.0738461538463,3143.067692307692,3130.0615384615385,3117.0553846153844,3104.0492307692307,3091.043076923077,3078.036923076923,3065.0307692307692,3052.0246153846156,3039.0184615384615,3026.012307692308,3013.0061538461537,{"y":3000,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2344.04,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2615.36,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2797.92,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3068.49,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3357.56,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3386.13,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3086.26,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3000.52,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3000.52,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3029.59,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2393.69,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2769.48,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3169.08,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Jupiter Life Line Hospitals Ltd.
                    Krsnaa Diagnostics Limited
                    Metropolis Healthcare Ltd.
                    Thyrocare Technologies Ltd
                    Vijaya Diagnostic Centre Ltd.
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis